In last trading session, Leap Therapeutics Inc (NASDAQ:LPTX) saw 69582.0 shares changing hands with its beta currently measuring 0.32. Company’s recent per share price level of $1.90 trading at $0.21 or 12.43% at ring of the bell on the day assigns it a market valuation of $72.69M. That closing price of LPTX’s stock is at a discount of -163.16% from its 52-week high price of $5.00 and is indicating a premium of 34.74% from its 52-week low price of $1.24. Taking a look at company’s average trading volume volume of 296.15K if we extend that period to 3-months.
For Leap Therapeutics Inc (LPTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.40. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Leap Therapeutics Inc (NASDAQ:LPTX) trade information
Upright in the green during last session for gaining 12.43%, in the last five days LPTX remained trading in the green while hitting it’s week-highest on Monday, 07/01/24 when the stock touched $1.90 price level, adding 5.0% to its value on the day. Leap Therapeutics Inc’s shares saw a change of -54.16% in year-to-date performance and have moved 7.95% in past 5-day. Leap Therapeutics Inc (NASDAQ:LPTX) showed a performance of -23.39% in past 30-days.
Wall Street analysts have assigned a consensus price target of 5.5 to the stock, which implies a rise of 65.45% to its current value. Analysts have been projecting 5.5 as a low price target for the stock while placing it at a high target of 5.5. It follows that stock’s current price would drop -189.47% in reaching the projected high whereas dropping to the targeted low would mean a loss of -189.47% for stock’s current value.
Leap Therapeutics Inc (LPTX) estimates and forecasts
Statistics highlight that Leap Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -59.31% of value to its shares in past 6 months, showing an annual growth rate of 58.29% while that of industry is 15.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 28.36% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 58.74% while estimates for its earnings growth in next 5 years are of -2.49%.
LPTX Dividends
Leap Therapeutics Inc is more likely to be releasing its next quarterly report in August and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
